OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 01, 2010
Combine Mechanistic Modeling and DoE to Streamline QbD
Too many REMS cause headaches for doctors and the industry.
Use it label-free, or add labels to detect contaminants in solution.
What small biotechs need to know about quality management systems.
An in-depth analysis of the patent provisions of the new legislation.
The third holy grail of biosimilars: interchangeability.
How current economic conditions affect your build-or-buy decision.
Develop a relevant design space without full factorial DoE.